1.
Hosokawa K, Katagiri T, Sugimori N, Ishiyama K, Sasaki Y, Seiki Y, Sato-Otsubo A, Sanada M, Ogawa S, Nakao S. Favorable outcome of patients who have 13q deletion: a suggestion for revision of the WHO ‘MDS-U’ designation. Haematologica [Internet]. 2012Nov.30 [cited 2026Nov.22];97(12):1845-9. Available from: https://haematologica.org/article/view/6499